Methotrexat maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats

This publication has 28 references indexed in Scilit:

• Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins
  Bone, 1996
• Changes in urinary deoxypyridinoline level and vertebral bone mass in the development of adjuvant-induced arthritis in rats
  Bone, 1995
• CIRCULATING CONCENTRATIONS AND PRODUCTION OF CYTOKINES AND SOLUBLE RECEPTORS IN RHEUMATOID ARTHRITIS PATIENTS: EFFECTS OF A SINGLE DOSE METHOTREXATE
  Rheumatology, 1994
• Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy
  Journal of Bone and Mineral Research, 1994
• Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: Evidence for an early bone formation defect
  Journal of Bone and Mineral Research, 1993
• Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic lewis rats treated with cyclosporin A or indomethacin
  Clinical Immunology and Immunopathology, 1990
• Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs
  Inflammation Research, 1988
• Methotrexate Inhibits the Human C5a-Induced Skin Response in Patients With Psoriasis
  Journal of Investigative Dermatology, 1987
• Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
  New England Journal of Medicine, 1985
• Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.
  Journal of Clinical Investigation, 1983